Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06011590
Other study ID # 1244/2022
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2000
Est. completion date July 31, 2022

Study information

Verified date August 2023
Source Medical University Innsbruck
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Over the past decades, several ECG-based parameters have been identified as independent predictors of worsened prognosis in affected patients. In addition to visual assessment of morphology, methods of computer-based machine ECG analysis have gained importance in recent years. These methods allow the detection of systemic abnormalities in ECGs that are not visible to the naked eye. An example of this is provided by the so-called "QRS microfragmentations". The aim of this evaluation is to retrospectively collect all established as well as new quantitative and qualitative ECG parameters (such as QRS microfragmentation) in a large patient collective. Subsequently, after characterization of the patients, an independent multivariate risk prediction model should be developed based on computer-based ECG analysis using maschnine learning algorithms.


Recruitment information / eligibility

Status Completed
Enrollment 150000
Est. completion date July 31, 2022
Est. primary completion date July 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients who presented to the Department of Internal Medicine at the Medical University in Innsbruck between 01.01.2000 and 31.07.2022 and received an ECG recording as part of routine clinical practice. - Age = 18 years - Residence in Austria Exclusion Criteria: - Insuffizient ECG Recording quality

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention.
No intervention.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Medical University Innsbruck

Outcome

Type Measure Description Time frame Safety issue
Primary All cause mortality Death of any cause between 01.01.2000 and 31.07.2022
Secondary Hospitalization Unplanned Hospitalization between 01.01.2000 and 31.07.2022
Secondary Lenght of hospital stay Lenght of hospital stay between 01.01.2000 and 31.07.2022
See also
  Status Clinical Trial Phase
Completed NCT02936089 - Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+ N/A
Enrolling by invitation NCT05979870 - Artificial Intelligence in New Cardiac MR Markers for Congenital Heart Disease
Completed NCT03690128 - Individual Early Warning Score (I-EWS) N/A
Completed NCT03652402 - Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN
Not yet recruiting NCT06306755 - Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer N/A
Completed NCT03263949 - Predicting Ventricular Tachyarrhythmias Following Acute ST Elevation Myocardial Infarction
Completed NCT05066386 - Improving the Accuracy of Revised Cardiac Risk Index With HbA1C:Hemoglobin Ratio (HH Ratio)
Active, not recruiting NCT06451302 - Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study N/A
Terminated NCT03207373 - Stress ECG Test for the Evaluation of the Risk of Sudden Cardiac Death in a Paediatric Cohort With WPW Pattern N/A